DK1423407T3 - 4-halogenerede 17-methylensteroider, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende disse forbindelser - Google Patents

4-halogenerede 17-methylensteroider, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende disse forbindelser

Info

Publication number
DK1423407T3
DK1423407T3 DK01978315T DK01978315T DK1423407T3 DK 1423407 T3 DK1423407 T3 DK 1423407T3 DK 01978315 T DK01978315 T DK 01978315T DK 01978315 T DK01978315 T DK 01978315T DK 1423407 T3 DK1423407 T3 DK 1423407T3
Authority
DK
Denmark
Prior art keywords
compounds
halogenated
preparation
pharmaceutical preparations
preparations containing
Prior art date
Application number
DK01978315T
Other languages
Danish (da)
English (en)
Inventor
Bernd Menzenbach
Walter Elger
Peter Droescher
Alexander Hillisch
Guenter Kaufmann
Hans-Udo Schweikert
Gerd Mueller
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK1423407T3 publication Critical patent/DK1423407T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01978315T 2000-09-04 2001-08-29 4-halogenerede 17-methylensteroider, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende disse forbindelser DK1423407T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10043846A DE10043846A1 (de) 2000-09-04 2000-09-04 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
DK1423407T3 true DK1423407T3 (da) 2006-07-03

Family

ID=7655148

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01978315T DK1423407T3 (da) 2000-09-04 2001-08-29 4-halogenerede 17-methylensteroider, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende disse forbindelser

Country Status (29)

Country Link
EP (1) EP1423407B1 (no)
JP (1) JP2004513084A (no)
KR (1) KR100530816B1 (no)
CN (1) CN1262560C (no)
AT (1) ATE319733T1 (no)
AU (2) AU2002210470B2 (no)
BG (1) BG107594A (no)
BR (1) BR0113618A (no)
CA (1) CA2421302C (no)
DE (2) DE10043846A1 (no)
DK (1) DK1423407T3 (no)
EA (1) EA006387B1 (no)
EE (1) EE05186B1 (no)
ES (1) ES2260294T3 (no)
HK (1) HK1060135A1 (no)
HR (1) HRP20030256A2 (no)
HU (1) HUP0300936A3 (no)
IL (2) IL154666A0 (no)
ME (1) MEP14408A (no)
MX (1) MXPA03001912A (no)
NO (1) NO325012B1 (no)
NZ (1) NZ524485A (no)
PL (1) PL360669A1 (no)
PT (1) PT1423407E (no)
RS (1) RS50305B (no)
SK (1) SK286757B6 (no)
UA (1) UA74592C2 (no)
WO (1) WO2002019971A1 (no)
ZA (1) ZA200301715B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141984A1 (de) * 2001-08-28 2003-03-20 Jenapharm Gmbh Neue 17-Methylen-4-azasteroide
US7199115B2 (en) 2004-04-19 2007-04-03 Schering Ag 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them
AT12800U1 (de) * 2007-11-05 2012-11-15 Bayer Schering Pharma Ag Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611773A (en) * 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US3146239A (en) * 1957-09-23 1964-08-25 Syntex Corp 4-halo-19-nor-progesterone
US3232960A (en) * 1959-10-08 1966-02-01 Upjohn Co 3-keto-4-fluoro- and 3-keto-4,4-difluorosteroids and process
US3661940A (en) * 1970-04-13 1972-05-09 Sandoz Ag Derivatives of 21-methyl-19-norpregnanes
US4389345A (en) * 1981-10-09 1983-06-21 G.D. Searle & Co. 3-Oxoestra-17-acetonitrile and unsaturated analogs
US5994334A (en) * 1997-02-05 1999-11-30 University Of Maryland Androgen synthesis inhibitors
WO2002000681A1 (en) * 2000-06-27 2002-01-03 Aventis Pharma S.A. 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase

Also Published As

Publication number Publication date
WO2002019971A1 (de) 2002-03-14
SK2442003A3 (en) 2003-08-05
DE50109175D1 (de) 2006-05-04
SK286757B6 (sk) 2009-05-07
ZA200301715B (en) 2004-08-13
CN1452628A (zh) 2003-10-29
NO325012B1 (no) 2008-01-14
PL360669A1 (en) 2004-09-20
WO2002019971A9 (de) 2002-08-08
HUP0300936A2 (hu) 2003-11-28
MEP14408A (en) 2010-06-10
EE05186B1 (et) 2009-06-15
HUP0300936A3 (en) 2010-01-28
BR0113618A (pt) 2003-07-15
RS50305B (sr) 2009-09-08
MXPA03001912A (es) 2004-07-08
EA200300322A1 (ru) 2003-10-30
CA2421302A1 (en) 2003-03-03
PT1423407E (pt) 2006-07-31
UA74592C2 (en) 2006-01-16
IL154666A (en) 2008-12-29
KR100530816B1 (ko) 2005-11-25
DE10043846A1 (de) 2002-04-04
YU16403A (sh) 2006-05-25
EA006387B1 (ru) 2005-12-29
EE200300087A (et) 2005-02-15
HRP20030256A2 (en) 2005-10-31
CA2421302C (en) 2007-08-14
NO20030989L (no) 2003-05-02
EP1423407A1 (de) 2004-06-02
BG107594A (bg) 2003-09-30
AU2002210470B2 (en) 2006-07-20
IL154666A0 (en) 2003-09-17
KR20030028836A (ko) 2003-04-10
AU1047002A (en) 2002-03-22
NZ524485A (en) 2005-11-25
NO20030989D0 (no) 2003-03-03
ATE319733T1 (de) 2006-03-15
EP1423407B1 (de) 2006-03-08
JP2004513084A (ja) 2004-04-30
ES2260294T3 (es) 2006-11-01
HK1060135A1 (en) 2004-07-30
CN1262560C (zh) 2006-07-05

Similar Documents

Publication Publication Date Title
UA66861C2 (uk) 2-феніл-1-[4-(2-аміноетокси)бензил]індол в комбінації з естрогенами, способи лікування та продукт для лікування
MA26843A1 (fr) NOUVELLES COMPOSITIONS ESTRO-PROGESTATIVES TOPIQUES à EFFET SYSTÉMIQUE
DE60040547D1 (de) Verfahren zur behandlung von birkenrinde und die isolierung von natürlichen produkten davon
RS49756B (sr) Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
MX9702170A (es) Uso de inhibidores de la aromatasa para la produccion de un agente farmaceutico para el tratamiento de una deficiencia de androgeno relativa en los hombres.
NO20053626L (no) Blanding omfattende en kombinasjon av en aromataseinhibitor, et progestin og et ostrogen for anvendelse av behandling av endomeriose
ATE279208T1 (de) Verfahren und stoffe zur behandlung des prostatakarzinomes
DE60115274D1 (de) Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
NO984075D0 (no) Kombinasjon av dehydroepiandrosteron og aromatasehemmere og anvendelse av denne kombinasjon for fremstilling av et legemiddel for behandling av en relativ og absolutt androgen mangel hos menn
DK1423407T3 (da) 4-halogenerede 17-methylensteroider, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende disse forbindelser
WO2002074315A8 (de) Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie
RS20050816A (en) Pure d-(17alpha)-13-ethyl-17-hydroxy- 18,19-dinopregn-4-ene- 20-yne-3-one-3e- and-3z-oxime isomers,as well as process for the synthesis of the mixture of isomers and the pure isomers
JPH0733673A (ja) テストステロン−５α−リダクターゼ阻害剤
DE59907558D1 (de) Mittel zur stabilisierung von lebensmitteln und kosmetischen mitteln sowie verfahren zu dessen herstellung
WO2003045971A3 (en) Solvates of 3.beta., 28-diacetoxy-18-oxo-19, 20, 21, 29, 30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof
DE60118363D1 (de) Methoden zur behandlung des kryptorchysmus
AR032371A1 (es) Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas